Association of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of (177)Lu-PSMA-617 Meeting Abstract
| Authors: | De Bono, J. S.; Morris, M. J.; Sartor, A. O.; Wei, X. X.; Fizazi, K.; Herrmann, K.; Piulats, J. M.; Mahammedi, H.; Logothetis, C.; George, D. J.; Wong, C.; Barys, L.; Rajagopal, N.; Alanee, S.; Chi, K. N. |
| Abstract Title: | Association of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of (177)Lu-PSMA-617 |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454740300011 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.16 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 16 -- Source: Wos |
